rs2529438
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_002047.4(GARS1):c.93G>A(p.Leu31Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000127 in 1,580,308 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L31L) has been classified as Benign.
Frequency
Consequence
NM_002047.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARS1 | NM_002047.4 | c.93G>A | p.Leu31Leu | synonymous_variant | 1/17 | ENST00000389266.8 | NP_002038.2 | |
GARS1 | NM_001316772.1 | c.-70G>A | 5_prime_UTR_variant | 1/17 | NP_001303701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.93G>A | p.Leu31Leu | synonymous_variant | 1/17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.93G>A | p.Leu31Leu | synonymous_variant | 1/17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.93G>A | p.Leu31Leu | synonymous_variant | 1/16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.18+75G>A | intron_variant | ENSP00000502174.1 | ||||||
GARS1 | ENST00000675051.1 | c.22-3782G>A | intron_variant | ENSP00000502296.1 | ||||||
GARS1 | ENST00000674815.1 | c.-148+62G>A | intron_variant | ENSP00000502799.1 | ||||||
GARS1 | ENST00000674851.1 | c.-184+62G>A | intron_variant | ENSP00000502451.1 | ||||||
GARS1 | ENST00000444666.6 | n.93G>A | non_coding_transcript_exon_variant | 1/18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.93G>A | non_coding_transcript_exon_variant | 1/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.93G>A | non_coding_transcript_exon_variant | 1/17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.93G>A | non_coding_transcript_exon_variant | 1/18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.93G>A | non_coding_transcript_exon_variant | 1/16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.93G>A | non_coding_transcript_exon_variant | 1/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.93G>A | non_coding_transcript_exon_variant | 1/15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.93G>A | non_coding_transcript_exon_variant | 1/19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.93G>A | non_coding_transcript_exon_variant | 1/17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.93G>A | non_coding_transcript_exon_variant | 1/17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.93G>A | non_coding_transcript_exon_variant | 1/18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.93G>A | non_coding_transcript_exon_variant | 1/17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.93G>A | non_coding_transcript_exon_variant | 1/16 | ENSP00000502681.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 33
GnomAD4 exome AF: 7.00e-7 AC: 1AN: 1428188Hom.: 0 Cov.: 31 AF XY: 0.00000141 AC XY: 1AN XY: 709234
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 21, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at